Henry Schein Completes Strategic Investment in BioHorizons

Henry Schein (NASDAQ: HSIC ) today announced the completion of a 60% equity investment in BioHorizons, Inc., a U.S.-based manufacturer of advanced dental implant technology and tissue regeneration products sold globally. This transaction was first announced on November 26, 2013. See full press release (c) 2013